UCSF Helen Diller Family Comprehensive Cancer Ctr
@UCSFCancer
Followers
10K
Following
17K
Media
3K
Statuses
14K
Championing basic science, clinical research, epidemiology/cancer control, and patient care. Contact: [email protected]
San Francisco
Joined September 2011
The overall cancer death rate is declining steadily in the US, and more individuals are living longer and fuller lives after a cancer diagnosis. Read about the research-driven progress during National Cancer Research Month—#NCRM25: https://t.co/u8C3eiZgyb
#UnitedByCancerResearch
3
13
26
May is National Cancer Research Month. Dr. LoRusso, AACR Past President, explains how basic research is essential to accelerating advances in cancer science and medicine. Learn more in the @AACR Cancer Progress Report: https://t.co/XlJKPVQ7sg
#NCRM25 #UnitedByCancerResaerch
0
8
20
“The field as a whole, in the last 10 years, has gone incredibly fast to come up with innovative molecules to target KRAS” @kevansf @UCSF in #AACR25 Keynote | Addressing KRAS Resistance, RAS(ON) Therapies Find Limelight at AACR https://t.co/Nqkjeqa6JL
@aacr
0
0
3
Donʻt miss today, May 1st at 4pm: Maria Castro, PhD @castro2355_mg @umich presents "Epigenetic reprogramming of the immune microenvironment in H3G34R pediatric high-grade gliomas" at our Friday Seminar Series @UCSF
https://t.co/qsEwJpNcWH
0
1
11
Congratulations to UCSF's Sophia Miliotis on taking home first place at the 2025 @UofCalifornia Grad Slam!
2
5
20
Successfully presented my research on Exarafenib at #AACR25 today. Grateful to the session chairs for their valuable feedback and support. Looking forward to the future of BRAF-targeted therapies in cancer! #CancerResearch #LungCancer #BRAF
0
2
6
Friday, May 1st at 4pm: Maria Castro, PhD @castro2355_mg @umich presents "Epigenetic reprogramming of the immune microenvironment in H3G34R pediatric high-grade gliomas" at our @UCSF Friday Seminar Series in Basic and Translational Research https://t.co/O5mcT4hnGC
1
1
20
Tues, April 30th 10:15 AM CT | @UCSF at #AACR25 | Xiaokun Shu, PhD, presents "New physical biology of oncoprotein condensates: Differential regulation of the transcriptome by phase separation" at @aacr. Session preview: https://t.co/EbHBXm8FL0
0
1
4
Wednesday, April 30th 12:39 PM CT | @UCSF at #AACR25 | Plenary Session on meeting highlights and Vision for the Future. Scarlett Gomez, PhD, MPH @UCSF_Epibiostat will present. https://t.co/jicDPDQlyG
0
1
1
Catch the @BivonaLabUCSF team at #AACR25 on April 29th! @Tadashi_Manabe | 2:30–4:00 PM Minisymposium, Room S102 @YTChou | 2:00–5:00 PM Section 18, Board 19 Nilanjana Chatterjee | 2:00–5:00 PM Section 17, Board 5 We’ll be sharing our latest research @UCSFCancer
0
1
2
Kicking off the Frontiers in Computational Health Conference 2025! @UCBerkeley Vice Chancellor for Research, Kathy Yelick - Welcome by co-directors @Idasim @DrMayaPetersen @UCJointCPH @BerkeleyCTML
https://t.co/VhcHZqDsyU
@UCSF
0
5
6
Excited to share that our work was published in @JCO_ASCO! A report from the @COGorg: stem cell transplantation is associated with improved outcomes for children diagnosed with high-risk acute myeloid leukemia (AML). https://t.co/KAXArCd7Fp
ascopubs.org
PURPOSEHematopoietic stem cell transplantation (HSCT) is used as consolidation for pediatric patients with high-risk AML in first complete remission (CR1). The definition of high-risk AML has evolved...
1
1
3
🚨🧬Everything you wanted to know about actionable #neoantigens resulting from cancer mutations besides point mutations (*but were afraid to ask). Join us at 10:15 in 📍Room E351 - McCormick Lakeside Center (Level 3)! @MSKCancerCenter @UCSFCancer @institut_curie
Join cellular therapist & early drug development specialist Dr. Christopher Klebanoff (@KlebanoffLab) for a symposium titled “Therapeutic targeting of public neoantigens resulting from recurrent gene fusions and mRNA mis-splicing events” today at #AACR25 (@AACR). Learn more:
1
3
31
At the #AACR25 plenary, Matthew Krummel, PhD, (@UCSFCancer) explores therapeutic strategies to reshape the tumor micro- and macroenvironment, including 12 tumor immune archetypes that may help uncover novel targeted treatments. Read more: https://t.co/xVHeBTJbTo
#MoffittAACR25
0
6
13
UCSF neurosurgery experts including Drs. Shawn @HerveyJumper, @robcosorio, Praveen Mummaneni & Dr. Nima Alan presented new research & clinical findings at the prestigious @AANSNeuro Annual Scientific Meeting in Boston. #AANS2025 Details on their talks ➡️ https://t.co/UMGdwmeAQx
2
5
17
Check out our podium at #AUA25 tomorrow discussing upstream regulators of STEAP1 in prostate cancer, presented by Dr. Sasha Zhu @UCSFUrology @UCSFCancer
https://t.co/qGWfTSLSli
0
1
3
Excited to present my research on Exarafenib at #AACR25 tomorrow. My work demonstrates promising efficacy against all classes of BRAF mutations in NSCLC, especially Class 2/3 that lack treatment options. #CancerResearch #BRAF #LungCancer
Tuesday, April 29th 2:50 PM CT | @UCSF at #AACR25 | @Tadashi_Manabe @bivonalab presents "Unveiling the potent anti-tumor activity and underlying mechanism of action of the novel pan-RAF inhibitor exarafenib in BRAF-mutated NSCLCr" https://t.co/yD8ePH6FI0
1
3
10
Tuesday, April 29th 10:45 AM CT | @UCSF at #AACR25 | Major Symposium: Immunology with Hideho Okada, MD, PhD presenting "Tumor-wide RNA splicing aberrations generate therapeutically actionable public neoantigens" at https://t.co/fi5fcU39ye
@aacr
0
2
5